PREVERLANCES OF SEXUALLY TRANSMITTED DISEASES IN PEOPLE
AGED BETWEEN 15 TO 50 YEARS IN HOIMA HOSPITAL,
HOIMA MUNICIPALITY
BY
KASOZI IGA EDWIN
(CLINICAL OFFICER TRAININEE)
November, 2021
APPROVAL
This is to clarify that KASOZI IGA EDWIN carried out this research proposal entitled “Prevalence of sexually
transmitted diseases in people aged between 15 to 50 years in Hoima hospital, Hoima municipality” and
has been done under my supervision and submitted under my approval.
Signature…………………………………………………………..
Miss Sr. Josephine Oyella.
(SUPERVISOR)
Date……………………………………….
DECLARATION
I KASOZI IGA EDWIN hereby declare that the work presented in this proposal is not my very own and has
never been presented for any academic award in any institution
Signature………………………………………………..
KASOZI IGA EDWIN
UA/DCM/044/18
(RESEARCHER)
Date…………………………………….
TABLE OF CONTENTS
Approval
DECLARATION…………………………………………………………………………………………………………………………. i
TABLE OF CONTENTS
LIST OF ACROYNYMS…………………………………………………………………………………………………………………… ii
DEFINITION OF TERMS
CHARPTER ONE: INTRODUCTION
BACKGROUND OF STUDY
STATEMENT OF THE PROBLEM
GENERAL OBJECTIVES
SPECIFIC OBJECTIVES
RESEARCH QUESTIONS
SIGNIFICANCE OF THE STUDY
SCOPE OF THE STUDY
CHARPTER TWO: LITERATURE REVIEW
DISTRIBUTION OF STDs ACCORDING TO DEMOGRATIC CHARACTERISTICS
MONTHLY DISTRIBUTION OF STDs
CHARPTER THREE: METHODOLOGY
STUDY DESIGN
STUDY AREA
STUDY POPULATION
SAMPLE SIZE DETERMINATION
SAMPLING TECHNIQUE
SAMPLING PROCEDURE
DATA COLLECTION METHOD
DATA COLLECTION TOOLS
DATA COLLECTION PROCEDURE
QUALITY CONTROL
DATA ANALYSIS AND PRESENTATION
ETHICAL CONSIDERATIONS
LIMITATIONS OF STUDY
DESEMINATION OF RESULTS
REFFERENCES
APPENDIX I CONSENT FORM
APPENDIX II:QUESTIONAIRES
APPENDIX III: BUDGET
APPENDIX IV: WORK PLAN
APPENDIX V: A MAP SHOWING THE LOCATION OF
LIST OF ACRONYMES
RPR
: Rapid Plasma Reaction
GUD : Genital Ulcer Diseases
STD
: Sexually transmitted Diseases
STI
: Sexually Transmitted Infections
MOH : Ministry of Health
WHO : World Health Organization
PHC
: Primary Health Care
AIDS : Acquired Immune Deficiency Syndrome
HIV
: Human Immune Virus
NGU : Non Gonococcal Urethritis
PID : Pelvic Inflammatory Disease
VCT : Voluntary Counseling and Testing
BV : Bacterial Vaginosis
ELISA : Enzyme Linked Immuno-Sorbent Assay
ARV : Anti-retro Viral
HBV : Hepatitis B Virus
HSV : Herpes Simplex Virus
PCR : Polymerase Chain Reaction
TOM : Tubal-Ovarian Mass
HPV : Human Papiloma Virus
VDRL: Venereal Disease Research Laboratories
RPR : Rapid Plasma Reaction Genital Ulcer Disease
UDS : Urethral Discharge Syndrome
LGV: Lymph Granuloma Veneria
ART: Anti-retro viral Therapy
MOH : Ministry of Health
OPD : Out Patient Department
ENT : Ear Nose and Throat
MICH : Material Child Health
US : United states
DEFINITION OF TERMS
Ectopic pregnancy : Is the implantation of the fertilized ovum outside the
uterus
Orchitis
: Is the inflammation of the testis
Prostatis
: Is the inflammation of the epidermis and testis
Urethral Stricture :is the narrowing of the urethra.
Infertility
:is the inability of the couple to achieve pregnancy after
sexual intercourse without contraceptive for one year
repeated
Balanitis :is the inflammation of the glans penis and the prepuce
Buboes:these are localosed swelling or enlarged lymph glandsinthe groin and femerol area.
Bartholin’s absceess:this is a complicationof gonoria or chalamydia linfection of the
Bartholin’sgland in women presents as an extremely painfullswelling at vaginal introitusss
Prepuce :foreskin covering the glans penissssssssssssss
Chapter one: Introduction
1.1Background to the study
Sexually transmitted diseases are infectious diseases caused by one or more microorganisms that
are mainly transmitted from one person to another during unprotected sexual intercourse.
The risk of transmission of sexually transmitted diseases from one infected person to another varies
according to the causative organism of the particular STI. For instance as many as one out of two
sexual partners of a patient with gonococcal urethritis may be infected after a single act of sexual
intercourse. On the other hand, the risk of transmission of HIV after a single act of sexual
intercourse in the absence of the other STI lesions may be as low as 0.1 to 1 percent. (Ministry of
Health 2018).
Sexually transmitted diseases can also be defined as infections that are transmitted from one person
to another through sexual contact and close body contact with infected body fluids. (World Health
Organization 2019).
There are more than 30 different kinds of sexually transmitted diseases that are spread through
vaginal, anal and oral sex, some can be spread by kissing or passed from a woman to her
developing fetus during pregnancy or child birth.
STDs are also called venereal diseases (VD) and usually present with the following signs and
symptoms:
Urethral or vaginal discharge in urethritis, vaginitis and rarely cervicitis, Sores or wounds in the
mucous membrane or skin of or near the genitalia (genital ulcers), abnormal swelling of the
lympnodes or groin (buboes) and abnormal growth of genital parts of other neighboring areas in
both men and women (warts). STDs which usually present with urethral or vaginal discharge are
either caused by gonococcal or non-gonococcal urethritis usually of men and trichomonal
infection. Genital sores or lumps near the genitalia which are usually sexually transmitted have a
large number of causes, but the most common in the tropics is syphilis others include
lymphogranuloma inguinale , chancroid or soft sore
Herpes genitalis and condylomata accumulate or venereal warts. Genital warts also show abnormal
growth of the genital parts or the neighboring area of both sexes. (Sexually Transmitted Infections
and sexually Transmitted Diseases textbook 2011).
However, most people with STIs such as gonococcal and non-gonococcal cervicitis, syphilis, HIV
and many others may be asymptomatic or mildly asymptomatic for a long period of time, but still
infectious and at risk of complications and disease progression. Such people can spread the
infection to uninfected sexual partners during sexual intercourse and such contact goes on to
develop disease and complications.
For this reason, a more inclusive term of sexually transmitted infections "(STI)" is recommended.
There are various etiological classifications of STDs, they are grouped into 5 groups according to
the causative agents namely:Bacterial STIs, this category includes, gonorrhea, syphilis, chancroid, LGV, non-gonococcal
genital infection and bacterial vaginosis.
Viral STIs for example genital herpes, viral warts, HIV and HBV.
Protozoal STIs for example trichomoniasis.
Fungal infections for example genital candidiasis and ring worms.
Infections for example pubic lice and scabies.
However, sometimes sexually transmitted infections can be endogenous. These include vaginal
candidiasis and bacterial vaginosis. These are part of the endogenous reproductive tract infections
knowledge of this is important for the point of view of the patient's education and partner
management. (Ministry of Health 2018).
STDs is a worldwide problem with higher incidence in developing countries due to the following.
Inadequate treatment; Disruption in tradition sex education for adolescents; Labour migration from
one place to another without a fixed sexual partner; Unemployment within the urban setting
leading to sexual favors for money and this leads further spread when they return home; Polygamy
and Inadequate sensitization of the Communities about STD, their route of transmission and
preventive methods.
ln Uganda, the infection is throughout the country because of poverty, camp settlement, inadequate
treatment, stigma attached to the diseases, ignorance, increasing cases of rape, lack of screening
facilities and enough medical workers. Particularly in Hoima, STDs are more common in the city
this is due to the movement of people from the rural areas to urban areas looking for soft life",
commercial sex workers, high rate of alcohol consumption, over population.
The STDs are not age specific but the majority of the people infected are between 15 to 50 years
of age.
Control of STDs in the community can be done through making correct diagnosis, giving effective
treatment, counseling clients when first seen in the hospital to modify their sexual behavior, giving
health education to avoid contact and prevention of transmission through the ABCs (Abstinence,
Being faithful to sexual partner and use of Condoms) and carrying out surveillance (Uganda
Clinical guidelines 2016).
The complications of STDs are long term outcomes of untreated or poorly treated STDs. Most
STDs are associated with serious complications that can be avoided if early and appropriate
treatment is provided to patients.
The STI complications include those for gonococcal and non-gonococcal genital infection,
complications vary according to sex and anatomical site affected. In males they are urethral
stricture, seminal vasculitis, epididymo architis and reduction of spermatozoa in semen and male
Infertility. In females, there is pelvic inflammatory disease (PID), Tubo ovarian masses (TOM),
irregular and painful heavy menstrual bleeding, ectopic pregnancy and secondary infertility.
Complications in babies are Ophthalamia Neonatorum with the risk of corneal ulcer and
blindness.
Complications due to syphilis are: - Secondary syphilis (4 weeks to month) which is
characterized by non-itchy skin rash extending to the palms and soles, alopesia, enlarged discrete
lympnodes especially behind the ears (post auricular) and above and behind the elbows in wet
areas, flat topped swellings (syphilitic warts).
Latent syphilis, this may occur from the two years and characterized by asymptomatic infection
and may be detected by blood test VDRL or RPR.
Late syphilis, skin, characterized with lesions referred to as gummata, bone, leading to swelling
and thickening of affected bones, eyes characterized by iritis and choroidorectinitis, aortic valve
incompetence and aortic aneurysm, general paralysis of the insane and loss of sensation of the
feet leading to painless sores of the feet, macerated still birth, premature delivery, intrauterine
foetal growth Syphilis and pregnancy, late abortion, intrauterine foetal death with retardation,
live child born with congenital syphilis and transmission of HIV to the unborn child.
Other STIs are also associated with complications that may include:Genital ulcers which lead to fibrosis of the affected organs, venereal warts due to HPV are
associated with cancer of the cervix; HBV can cause chronic hepatitis that may predispose to
hepatocellular carcinoma and LGV Management of STD depends on identifying particular
disease causing the symptoms using laboratory procedures, clinical experience and syndromic
approach. (MOH Uganda 2018).
1.2 Statement of the problem
Sexually transmitted diseases form the second largest percentage next to malaria amongst the
diseases diagnosed in Ugandan hospitals. It forms about 40 percent of the diagnosed conditions
amongst out patients department OPD (MOH 2017, report).
It has been reported that STDs are more observed mostly in the 20 to 24 years old age group
followed by 25 to 29 and 15 to 19 years old.
Sexually transmitted diseases remains a public health problem worldwide with its serious
complications which includes abortion, infertility, ectopic pregnancy, foetal death. Pelvic
inflammatory disease, urethral stricture, Prostatitis on increase everywhere. It is estimated that
about 300 million people worldwide are seen with STD annually
According to Medical encyclopedia, about 80 percent PID worldwide is caused by STIs majorly
Trichomonas vaginalis, Chlamydia and gonorrhea.
This research study will therefore seek to determine the prevalence, distribution of STDs by sex,
ages, and location.
1.3 General of objective.
To assess the prevalence of STDs in Hoima city.
1.3.1 Specific Objectives
To determine the distribution of STDs by sex
To determine the distribution of STDs by age.
To establish the distribution of STDs by location.
To establish the monthly distribution of STDs.
1.3.2 Research Questions.
What are the demographic characteristics of patients diagnosed and treated with STDs in Hoima
hospital?
What is the monthly distribution of STD cases in Hoima hospital?
1.4 Significance of the study.
This information will help to generate solution towards preventing STDs.
To form a basis for other researchers who are interested in the same topic.
It is aimed at updating the medical personnel in Hoima hospital and the whole public about the
prevalence of STDs.
To identify persons at greater risk of getting STDs.
The researcher will develop a deeper insight into the field of conducting research.
1.5 Scope of the study
To assess the prevalence of STDs in Hoima hospital found in Hoima city. It will include all male
and female patients who will be diagnosed and treated at Hoima hospital with STDs between the
age group of 15 to 50 years including pregnant women, lactating mothers. It will exclude all
patients with STDs but below 15 and those above 50 years of age.
It will also exclude some minority tribes in Hoima municipality like southsudanese,
conglese,Madi,Kakwa,Indians,Arabs,Somalis especially those who can hardly share a common
language with the researcher because of language barrier and very high cost of hiring
interpreters.
The researcher will exclude homosexuals and lesiabians regardless of their willingness and
eligibility to participate in research because of the researcher’s faith in his beliefs which compel
him from such associations.
Chapter Two: Literature Review
Sexually transmitted diseases are infectious diseases caused by one or more microorganisms that
are mainly transmitted from one Infected Person to another during unprotected sexual intercourse.
The risk of transmission of STIs from one infected person to another varies According to the
causative organism of a particular STI. For instance, as many as one out of sexual partners of a
patient with
Gonococci urethritis may be infected after a single act of sexual Intercourse. On the other hand the
risk of sexual transmission of HIV after a single act of sexual intercourse in the absence of other
STI lesions may be as low as 0.1-1%. There are over 20 different types of STIs. The most common
presentations of these STIs are; a discharge from the penis (urethritis), a discharge from the vagina
(vaginitis and rarely cervicitis), sores or wound on the genital Part of both men and women (genital
ulcer), and abnormal growth on the Genital parts or other neighboring areas in both men and
women (warts). Some common STDs include: gonorrhea, genital candidiasis, Trichomoniasjs,
chancrojd, herpes genitalis, lymphogranuloma venerium (LGV), granuloma inguinal, syphilis,
non-gonococcal urethritis or Cervicitis, bacterial vaginosis. Hepatitis B virus infectious (I-IBV),
HIV/AIDS, scabies, venereal warts and ring worm. 2.2 Distribution of STDs according to
demographic characteristics. STDs constitute a significant cause of morbidity and mortality
worldwide. Particularly in developing countries. However, their importance had not been realized
till only recently in the wake of the H1V epidemic.
The Burden of STIs is high worldwide in terms of their associated morbidity, Mortality and social
economic impact (WHO 2017, Annual Report). In Uganda,STIs and related complications have
consistently ranked among the leading cause of outpatient consultation in public health facilities,
Accounting for about 20% of adult outpatient consultations in public health Facilities for many
years (Ministry of Health 2017,article in New Vision newspaper) At population level, one study
in rural Uganda found a high prevalence of STIs with up to 50% of adults 15-49 having at least
one STI (Ministry of Health 2017,article in New vision newspaper) According to CDC 2019
Surveillance, it has been estimated that Out of the 19 million STD infections that occur per year
in US at least half of them are Among the youth. However, studies done in developed countries
show that 50% of the people Develop full blown AIDS in ten years. The rate is thought to be faster
in Africa perhaps due to interaction with epidemic infections, infestations, Malnutrition, stress and
other factors. Worldwide the epidemic of HIV was first reported in early 1980s in the United
States and later in Africa and is now wide spread with more than sixty Million people infected
since then of whom at least twenty million people have died. In Uganda H1V epidemic was first
detected in 1982 in Rakai district. From This epicenter, the epidemic spread very rapidly
throughout the country, so That by early 90s, every district had reported a case of AIDS. It was
estimated that at the end of 2002, about two million people in Uganda were infected, with about
eight hundred thousand people living with the Infection and over one million deaths.
According to the sentinel Surveillance of H1V based on sero prevalence among antenatal
mothers Attending selected antenatal clinic surveillance sites, H1V is more prevalent In major
urban areas than in rural areas currently estimated at 5 to 10% and then 5% of adults
respectively. Than in males of the same age group. This is due to cross generation sex with girls
becoming sexually active at earlier age and having sex with older Men. (According to USAID
study 2018, article in New York Times).
Sexually transmitted diseases affect any sexually active individual, whether He or she had one
partner or many sexual partners. It affects both sexes but the raise is high in the age group of 15
to 30 years and more in females than Males, reason being that girls usually have sex earlier than
boys and with Older partners who are likely to be carrying the infection. In Hoima district it has
been reported that STDS are more observed mostly in the 20 to 24 years old age group followed
by 25 to 29 and 15 to 19 years old. (Hoima hospital referral records 2018)
2.1 Monthly distribution STDS.
In Uganda STD form the second largest percentage next to malaria amongst the disease
diagnosed in hospitals. It forms about 20% of Diagnosed conditions amongst OPD patients per
month. (MOH 2018 article in new vision newspapers).
Particularly in Hoima no study has been carried out to determine the Prevalence of STD per
month.
Chapter Three: Methodology
3.1 Study design.
A retrospective descriptive study will be used to determine the distribution of STDs by sex, age
and location among people aged between 15 and 50 years.
3.2 Study area.
This study will be conducted in Hoima hospital in Hoima district. Hoima is a relatively new city
located Northwest of Kampala with Kyankwanzi district in the east, Kibale district in the South,
Bulisa district in the north, lake Albert to the west. Hoima hospital is a referral hospital and
government founded, established in 1935 as district hospital but in 1994 it was upgraded to
referral status targeting Greater Bunyoro (Hoima, Kibale, Masindi, Bulisa, Kiryandogo,
Kyankwanzi and Kiboga) and has a catchment area of about three million people as estimated by
Uganda MOH 2019.
It is Located on atleast 12 acres of land. It has atleast 280 staff, with atleast 317 bed capacity.
Hoima hospital comprises of the following departments; OPD, Administration department and in
patient department. The OPD consists of the eye clinic, dental clinic, dispensary, TB clinic,
minor theatre, ART clinic, ENT clinic, diabetic clinic, antenatal clinic, outpatient laboratory,
Emergency unit, mother to child health clinic (MCH) and gynecological Clinic.
The ART clinic operates every day from 8:30am to 6:30 from Monday to Friday Whereas the STI
clinic only operates Tuesdays. The inpatient department comprises the children’s word, medical
ward, surgical ward, maternity ward, gynecology and obstetrics wards, and pharmacy, in patient
laboratory. Mortuary, Orthopedic department, operation theatres, staff quarters and stores.
The natives of Hoima Municipality are Banyoro, Buganda, Banyankole, lugbara, Bakiga and
Acholi also exists. The economy of Hoima district is based on Agriculture, business and
investments due to oil discoveries in 2000 to 2009 is the economic activity. Other economic
activities include: Fishing, cattle keeping.
The municipality experiences rainfall throughout the year with most rains in October and January
least rains.
3 .3 Study population
The study will target people aged between 15 years to 50 years who will be treated with STDs in
the OPD department during the period of research. On average atleast 900 people of age group
15 years to 50 years attend OPD services monthly.
3.4 sample size Determination.
Using Kish and Leslies (1995) formula for cross sectional studies will be used for determination
of the number of participants interviewed.
Asamplesizedeterminationwasconductedbyuseofstatisticalformulaforthesamplesizedetermination
asfollows:
Sample size, n=
Z2 Pq
d2
(usingKishandLeslie, 1965).
Where;
N is the desired sample size,
Z is normal standard deviation at the required confidence,
P is proportion of target population estimated to have the characteristics measured,
D is absolute precision (maximum error) and q=1-p.Therefore
Z=1.96(standard normal deviation at 95% confidence interval)
p=0.5(estimated prevalence 50%)
d=maximum error was 9.8% or 0.098
Then
1.962 x0.5x0.5
n=
0.0982
n=100
Therefore there was100 respondents used in the study
3.5 Sampling Techniques
A simple random sampling technique will be used by the researcher because selection of
respondents will be without bias and it is time saving compared to other sampling technique
3.6
sampling procedure
Simple random sampling method will be used to select respondents in the age range of 15years to
50 years who will be accessed when they come for STDs/STIs services during time of conduction
of this research from from Hoima referral hospital .Each respondent will be assigned a number
that will be placed in the box, from which a number will be picked at random without replacement,
such that each respondent has an equal chance of being selected to participate in the study.
3.7Data collection Method
Both qualitative and quantitative methods of data collection will be used. Interview method using
formal questionnaires will be administered .Also check-lists will be used to review records of
STDs cases in the records department of Hoima Referral hospital to collect data.The researcher
will introduce himself to the respondents ,read out the objectives of the study ,get consent from
them and continue with the study procedure.
3.8Data collection Tools
Data will be collected using an interview schedule questionnaires with both open and closed ended
questions. Appropriate explanation will be given to ensure understanding of the questions.
Standardized checklist will also be used to review records of STDs cases in Hoima referral
hospital.
3.9Data collection procedure
The respondents will be interviewed using an interview schedule questionnaire. The respondents
who know how to read and write, will be allowed to fill the questionnaire on their own. The
researcher will also read and interpret the questionnaire to some respondents to limit on the
incidence of errors. Those respondents who have difficulty in reading will be assisted by the
research assistants.
With the help of a records officer in the record department after obtaining permission from Hoima
Referral hospital administration the researcher will review records of STDs cases and extract
relevant information applicable in accordance to the objectives upon which this research is being
conducted
3.10Study Variables
In this study, prevalence of STDs is my dependent variable whereas age, sex and location are my
independent variables. This is because prevalence of STDs entirely depends on age, sex and
location (urban or rural) of individuals
3.11Quality control
To ensure validity and reliability, the questionnaire and checklist will be reviewed by the
research supervisors and colleagues for clarity prior to the exercise of data collection. The
information collected will be presented to the supervisor for verification. A preliminary study will
be carried out to test the accuracy and feasibility of the questionnaire. Research assistants will also
be trained on how to efficiently and effectively collect data and will be oriented on proper inclusion
and exclusion criteria of the study.
3.12Data Analysis and presentation
Data will be collected for analysis using questionnaires and checklists and verified Hoima Referred
hospital resourceful personnel (doctor, nurse) through checking of records. The scores of the
respondents will be tallied, tabulated and entered into an MS excel program for effective storage
and retrieval. Data will be entered into the computer statistical program (SSPS) for analyses.
Analyzed data will be presented in tables, charts, graphs, percentages and figures.
3.13Ethical Consideration
All research related ethical standards will be observed throughout the course of the study, data
collection will be after presentation of an introductory letter from the academic registrar Gulu
College of Health Sciences to Hoima Referral hospital administration and Hoima Municipality
Healthy Officer. Participation will be voluntary and informed consent will be obtained from each
participant prior to administering the questionnaire, Confidentiality will be maintained during the
sstudy process and no identification information will be collected.
3.14Study limitations
i.
Financial constraints will have a negative impact on the work since it will require typing,
photocopying, transport and facilitating research assistants who will help to translate to
those people with whom the research does not share any common language but are within
the target group for research.(Lugbara, Alur,Indians,Luos,west Nilers and others)
ii. Covid19 limits as gatherings are not allowed and hence meeting girls one by one consumes
time.
iii. The research will interfere with the researcher’s personal and academic time because it is
time consuming.
iv. Some respondents may choose to refuse being interviewed as they may not have time for the
researcher.
3.15Dissemination of Results
The findings from the study will be disseminated as follows; a copy to:
1. Uganda Allied Health Examination Board (UAHEB)
2. Hoima Referral Hospital
3. Gulu College of Health Sciences
4. Hoima Municipality health management Team
5. Any interested party who will wish to purchase the rights of the research
6. The supervisor
7. The researchers
1.
James C, Harfouche M, Welton NJ, et al. Herpes
simplex virus: global infection prevalence and incidence
estimates, 2016. Bull World Health Organ.
2020;98(5):315-329. doi:10.2471/BLT.19.237149
2.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre
LA, Jemal A. Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 2018
Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018
Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313.
PMID: 30207593.
https://doi.org/10.1371/journal.pone.0211720
3.
Unemo M, Lahra MM, Escher M, Eremin S, Cole MJ,
Galarza P, Ndowa F, Martin I, Dillon JR, Galas M, RamonPardo P, Weinstock H, Wi T. WHO global antimicrobial
resistance surveillance (GASP/GLASS) for Neisseria
gonorrhoeae 2017-2018: a retrospective observational
study. Lancet Microbe. September.
Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia,
gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull
World Health Organ. 2019;97(8):548–62P. pmid:31384073



View Article
PubMed/NCBI
Google Scholar
. Chitneni P, Bwana MB, Owembabazi M, O’Neil K, Kalyebara PK, Muyindike W, et al.
Sexually Transmitted Infection Prevalence Among Women at Risk for HIV Exposure Initiating
Safer Conception Care in Rural, Southwestern Uganda. Sex Transm Dis. 2020;47(8):e24–e8.
pmid:32404858



View Article
PubMed/NCBI
Google Scholar
. Uganda Clinical Guidelines 2016: National Guidelines for Management of Common
Conditions. In: The Republic of Uganda MoH, editor. Uganda: Ministry of Health Uganda;
2016.
Prevention, CDC – Centers for Disease Control and (2 May 2017). "Lice: Pubic". www.cdc.gov.
Retrieved 4 December 2017. This article incorporates text from this source, which is in the
public doma
Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. (July 2021).
"Sexually Transmitted Infections Treatment Guidelines, 2021" (PDF). MMWR Recomm Rep. 70
(4): 1–187. doi:10.15585/mmwr.rr7004a1. PMC 8344968. PMID 34292926.
"Molluscum Contagiosum". The Lecturio Medical Concept Library. Retrieved 27 August 2021
"Draft Recommendation Statement: Sexually Transmitted Infections: Behavioral Counseling US Preventive Services Task Force". www.uspreventiveservicestaskforce.org. Retrieved 19
December 2019
Lancet (2016). "Global, regional, and national incidence, prevalence, and years lived with
disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden
of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6.
PMC 5055577. PMID 27733282.
"Fact sheet – Latest statistics on the status of the AIDS epidemic | UNAIDS".
www.unaids.org. Archived from the original on July 13, 2017. Retrieved July 21, 2017.
Newman, Lori; Rowley, Jane; Vander Hoorn, Stephen; Wijesooriya, Nalinka Saman; Unemo,
Magnus; Low, Nicola; Stevens, Gretchen; Gottlieb, Sami; Kiarie, James; Temmerman, Marleen;
Meng, Zhefeng (8 December 2015). "Global Estimates of the Prevalence and Incidence of Four
Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global
Reporting". PLOS ONE. 10 (12): e0143304. Bibcode:2015PLoSO..1043304N.
doi:10.1371/journal.pone.0143304. PMC 4672879. PMID 26646541.
"Sexually transmitted infections". womenshealth.gov. 2017-02-22. Retrieved 2017-12-08.
This article incorporates text from this source, which is in the public domain.
Welch, Ashley. "Two-thirds of the world population has herpes". CBSNews. CBS News.
Retrieved 27 December 2017
Brunner & Suddarth's textbook of medical-surgical nursing (12th ed.). Philadelphia: Wolters
Kluwer Health/Lippincott Williams & Wilkins. 2010. p. 2144. ISBN 978-0-7817-8589-1.
Archived from the original on 18 May 2016.
epidemiology, clinical manifestations, and management". Annals of Pharmacotherapy. 42 (2):
226–36. doi:10.1345/aph.1K086. PMID 18212261. S2CID 23899851.
"Syphilis". CDC. 4 June 2015. Archived from the original on 21 February 2016. Retrieved
3 February 2016.
2016). "Global, regional, and national incidence, prevalence, and years lived with disability for
310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease
Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6.
PMC 5055577. PMID 27733282.
"Global,
regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249
causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015".
Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903.
PMID 27733281
Cantor, Amy; Nelson, Heidi D.; Daeges, Monica; Pappas, Miranda (2016). Screening for
Syphilis in Nonpregnant Adolescents and Adults: Systematic Review to Update the 2004 U.S.
Preventive Services Task Force Recommendation. U.S. Preventive Services Task Force Evidence
Syntheses, formerly Systematic Evidence Reviews. Agency for Healthcare Research and Quality
(US)
"Candida infections of the mouth, throat, and esophagus". Fungal Diseases. United
States: Centers for Disease Control and Prevention. 13 November 2019. Retrieved 24 Dec 2019.
"Candidiasis". Fungal Diseases. United States: Centers for Disease Control and
Prevention. 13 November 2019. Retrieved 24 Dec 2019.
"Risk & Prevention". cdc.gov. February 13, 2014. Retrieved 28 December 2014.
"Treatment & Outcomes of Oral Candidiasis". cdc.gov. February 13, 2014. Retrieved 28
December 2014.
"Oral Candidiasis Statistics". cdc.gov. February 13, 2014. Archived from the original on
29 December 2014. Retrieved 28 December 2014.
"Genital / vulvovaginal candidiasis (VVC)". cdc.gov. February 13, 2014. Archived from
the original on 29 December 2014. Retrieved 28 December 2014.
"Symptoms of Oral Candidiasis". cdc.gov. February 13, 2014. Archived from the original
on 29 December 2014. Retrieved 28 December 2014.
"Thrush in men and women". nhs.uk. 9 January 2018. Retrieved 16 March 2020.
"Symptoms of Genital / Vulvovaginal Candidiasis". cdc.gov. February 13, 2014. Archived
from the original on 29 December 2014. Retrieved 28 December 2014.
-04-01). "Histopathologic Diagnosis of Fungal Infections in
the 21st Century". Clinical Microbiology Reviews. American Society for Microbiology. 24 (2):
247–280. doi:10.1128/cmr.00053-10. ISSN 0893-8512. PMC 3122495. PMID 21482725.
8 August 2015). "Candidiasis: Workup". Medscape. WebMD.
Archived from the original on 11 June 2016. Retrieved 22 June 2016.
"Bacterial vaginosis: a review on clinical
trials with probiotics" (PDF). The New Microbiologica. 36 (3): 229–38. PMID 23912864.
Archived (PDF) from the original on 2015-05-18.
Postgraduate Medicine. 125 (3): 33–46. doi:10.3810/pgm.2013.05.2650. PMID 23748505.
S2CID 25586978.
involvement by non-dermatophytic fungi". The British Journal of Dermatology. 130 Suppl 43:
16–21. doi:10.1111/j.1365-2133.1994.tb06088.x. PMID 8186136. S2CID 37415499.
"What Are HIV and AIDS? | HIV.gov". www.hiv.gov. U.S. Department of Health and Human
Services (HHS). May 15, 2017. Archived from the original on September 22, 2019. Retrieved
September 10, 2017
"HIV Classification: CDC and WHO Staging Systems | AIDS Education and Training
Centers National Coordinating Resource Center (AETC NCRC)". aidsetc.org. AIDS Education
and Training Center Program. Archived from the original on October 18, 2017. Retrieved
September 10, 2017.
"Wear your red ribbon this World AIDS Day | UNAIDS". www.unaids.org. UNAIDS
Secretariat. Archived from the original on September 10, 2017. Retrieved September 10, 2017.
"HIV/AIDS Fact sheet N°360". World Health Organization. November 2015. Archived
from the original on February 17, 2016. Retrieved February 11, 2016.
"About HIV/AIDS". CDC. December 6, 2015. Archived from the original on February 24,
2016. Retrieved February 11, 2016.
UNAIDS (May 18, 2012). "The quest for an HIV vaccine". Archived from the original on May
24, 2012.
McCray, Eugene; Mermin, Jonathan (September 27, 2017). "Dear Colleague: September 27,
2017". Division of HIV/AIDS Prevention. Centers for Disease Control and Prevention. Archived
from the original on January 30, 2018. Retrieved February 1, 2018.
Coutsoudis A, Kwaan L, Thomson M (October 2010). "Prevention of vertical transmission of
HIV-1 in resource-limited settings". Expert Review of Anti-Infective Therapy. 8 (10): 1163–75.
doi:10.1586/eri.10.94. PMID 20954881. S2CID 46624541.
"WHO | Mother-to-child transmission of HIV". WHO. Archived from the original on
October 18, 2019. Retrieved December 27, 2019.
White AB, Mirjahangir JF, Horvath H, Anglemyer A, Read JS (October 2014).
"Antiretroviral interventions for preventing breast milk transmission of HIV". The Cochrane
Database of Systematic Reviews. 10 (10): CD011323. doi:10.1002/14651858.CD011323.
PMID 25280769.
"Infant feeding in the context of HIV". www.who.int. April 2011. Archived from the original
on March 9, 2017. Retrieved March 9, 2017
Unemo, M (21 August 2015). "Current and future antimicrobial treatment of gonorrhoea – the
rapidly evolving Neisseria gonorrhoeae continues to challenge". BMC Infectious Diseases. 15:
364. doi:10.1186/s12879-015-1029-2. PMC 4546108. PMID 26293005.
"Antibiotic-Resistant Gonorrhea Basic Information". CDC. 13 June 2016. Archived from the
original on 8 September 2016. Retrieved 27 August 2016.
"Gonorrhea – CDC Fact Sheet (Detailed Version)". CDC. 17 November 2015. Archived from the
original on 2 September 2016. Retrieved 27 August 2016
"Gonococcal Infections - 2015 STD Treatment Guidelines". 4 January 2018
Department of Reproductive Health and Research (2011). "Emergence of multi-drug resistant
Neisseria gonorrhoeae – Threat of global rise in untreatable sexually tr
ansmitted infections" (PDF). FactSheet WHO/RHR/11.14. World Health Organization.
"Gonorrhea – STD information from CDC". cdc.gov. 6 October 2017. Retrieved 5 December
2017
"Untreatable gonorrhoea 'superbug' spreading around world, WHO warns". The Daily
Telegraph. 7 July 2017. Archived from the original on 7 July 2017
Jerse, AE; Bash, MC; Russell, MW (20 March 2014). "Vaccines against gonorrhea:
current status and future challenges". Vaccine. 32 (14): 1579–87.
doi:10.1016/j.vaccine.2013.08.067. PMC 4682887. PMID 24016806.
Gottlieb, Sami L.; Johnston, Christine (2017). "Future prospects for new vaccines against
sexually transmitted infections". Curr Opin Infect Dis. 30 (1): 77–86.
doi:10.1097/QCO.0000000000000343. PMC 5325242. PMID 27922851.
Petousis-Harris, Helen (2017). "Effectiveness of a group B outer membrane vesicle
meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study".
Lancet. 390 (10102): 1603–1610. doi:10.1016/S0140-6736(17)31449-6. PMID 28705462.
S2CID 4230156.
GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 October 2016).
"Global, regional, and national incidence, prevalence, and years lived with disability for 310
diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study
2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577.
PMID 27733282.
Stevenson, Angus (2010). Oxford dictionary of English (3rd ed.). New York, NY: Oxford
University Press. p. 306. ISBN 9780199571123. Archived from the original on 10 September
2017. Retrieved 10 June 2016.
Byrne, Gerald I. (8 July 2003). "uncloaked". Proceedings of the National Academy of Sciences.
100 (14): 8040–8042. doi:10.1073/pnas.1533181100. PMC 166176. PMID 12835422. "The term
was coined based on the incorrect conclusion that Chlamydia are intracellular protozoan
pathogens that appear to cloak the nucleus of infected cells."
Witkin SS, Minis E, Athanasiou A, Leizer J, Linhares IM (October 2017). "Chlamydia
trachomatis: the Persistent Pathogen". Clinical and Vaccine Immunology.
-Ardila, CF; Torres, M; Gaitán, HG (29 January 2020). "Rapid point of care test for
detecting urogenital Chlamydia trachomatis infection in nonpregnant women and men at
reproductive age". The Cochrane Database of Systematic Reviews. 1: CD011708.
doi:10.1002/14651858.CD011708.pub2. PMC 6988850. PMID 31995238.
mond, S; Uusküla, A; van Bergen, J; Ward, H; Andersen, B; Götz, H (13
September 2016). "Screening for genital chlamydia infection". The Cochrane Database of
Systematic Reviews. 2016 (9): CD010866. doi:10.1002/14651858.CD010866.pub2.
PMC 6457643. PMID 27623210.
Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP
(2004). "Global data on visual impairment in the year 2002" (PDF). Bull World Health Organ.
82 (11): 844–851. doi:10.1590/S0042-96862004001100009 (inactive 31 October 2021).
PMC 2623053. PMID 15640920. Archived (PDF) from the original on 2008-06-25.
n E, McGarry C, Warrington R (2015). "STI testing in emergency
contraceptive consultations". British Journal of General Practice. 65 (631): 63–64.
doi:10.3399/bjgp15X683449. PMC 4325454. PMID 25624285.
M, Naber KG, Weidner W (2006). "Chlamydial infections and prostatitis in
men". BJU Int. 97 (4): 687–90. doi:10.1111/j.1464-410X.2006.06007.x. PMID 16536754.
S2CID 34481915.
-surgical nursing : assessment and management of
clinical problems. Bucher, Linda; Heitkemper, Margaret M. (Margaret McLean); Harding,
Mariann (10th ed.). St. Louis, Missouri. ISBN 978-0-323-32852-4. OCLC 944472408.
"Global data on blindness"
(PDF). Bull World Health Organ. 73 (1): 115–21. PMC 2486591. PMID 7704921. Archived
(PDF) from the original on 2008-06-25
.
APPENDIX I: CONSENT FORM
DEAR RESPONDANT
I AM KASOZI IGA EDWIN A 3 YEAR STUDENT OF COLLEGE OF HEALTH SCIENCES PERTAKING A DIPLOMA IN CLINICAL
MEDICINE AND COMMUNITY HEALTH CONDUCTING A STUDY ABOUT PREVALENCE OF SEXUALLY TRANSMITTED
DISEASES IN PEOPLE AGED BETWEEN 15 TH 50 YEARS AT THIS HEALTH FACILITY IN THIS STUDY YOU WILL BE
REQUIRED TO SIGN A CONSENT FORM AFTER UNDERSTANDING THE PROCEDURE ABOUT THE TOPIC OF STUDY.
I WILL ASK YOU QUESTIONS ABOUT THE STUDY AND YOUR RESPOSES SHALL BE RECORDED IN THE
QUESTIONNAIRE. THE DISCUSSION WILL TAKE ABOUT 10 TO 20 MINUTES.THERE WILL BE NO MATERIAL
COMPASATION IN THIS STUDY AND THE FINDINGS WILL DEFINE THE POSSIBLE MEASURES ON HOW SEXUALLY
TRANSMITTED DISEASE CAN BE PREVENTED. THE INFORMATION PROVIDED WILL BE HANDLED WITH OTHERMOST
CONFIDENTIALITY AND WILL NOT BE SHARED WITH ANY OTHER PERSON. YOUR IDENTITY WILL NOT BE REVEALED
ANYWHERE ON THE QUESTIONIARE. YOUR PERTICIPATION IN THIS STUDY IS VOLUNTARY AND YOU HAVE A CHOICE
NOT TO PERTICIPATE. YOU ARE ALSO FREE TO OPT OUT OF THE STUDY WHEN YOU ARE TIRED OR NOT INTERESTED.
YOU ARE FREE TO ASK ANY QUESTIONS THAT YOU FEEL YOU ARE UNCERTAIN ABOUT THE STUDY BEFORE THE
STUDY BEGINS.
I CONFIRM THAT ALL THE INFORMATION ABOUT THE ABOVE TOPIC HAS BEEN EXPLAINED TO ME AND TO MY
SATISFACTION AND MY QUESTIONS ARE TO BE ANSWERED TO MY OUTERMOST SATISFACTION.
I HEREBY ACCEPT TO PERTICIPATE IN THIS STUDY.
RESPONDANT’S SIGNATURE……………………………………………………. DATE………………………………
RESEARCHERS SIGNATURE……………………………………………………… DATE………………………………
NO
ITEM
1
STATIONARY
2
QUANTITY
UNIT
PRICE
TOTAL COST
A
PHOTOCOPYING PAPERS
1 REAM
15,000
15,000
B
PENS
5
500
2,500
C
FILE FOLDER
1
2,000
2,000
D
INTERPRETER INTENSIVES
5
20,000
100,000
10 DAYS
2,000
20,000
2
10,000
20,000
INTERNET SERVICES
TYPYING, PRINTING AND
PHOTOCOPYING
A
PROPOSAL
B
QUESTIONAIRE
C
REPORT
3
15,000
45,000
D
BINDING
5
3,000
15,000
E
REPORT HARD COVER
5
10,000
50,000
4
MISCELLANEOUS
5
TOTAL
400
50,000
APPENDIX IV: WORK PLAN
CONTENT ACTION
1
2
3
4
5
6
7
8
9
10
11
12
Writing proposal
Typing proposal
Analyzing proposal
Submitting proposal to the
supervisor
Corrections and retyping
Constructing and pretesting
instruments
Data collection
Data analysis
Report writing
Submit report to the supervisor
Correct, retyping and binding
report
Final report submission
SEPT
OCT
NOV
DEC
JAN
FEB
MAR
APR